Estrogen Receptor α Antagonists Mediate Changes in CCL20 and CXCL1 Secretions in the Murine Female Reproductive Tract

American Journal of Reproductive Immunology

Volumn 69, Issue 2, 2013, Pages 159-167

  Hickey, Danica K ^a   Fahey, John V ^a   Wira, Charles R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Antimicrobial; Chemokine; Estradiol; Estrous cycle; Selective estrogen receptor modulators; Uterus; Vagina

Indexed keywords

6 HYDROXY 2 (4 HYDROXYPHENYL)BENZO[B]THIEN 3 [4 [4 (1 METHYLETHYL) 1 PIPERAZINYL]PHENYL]METHANONE; CXCL1 CHEMOKINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG; Y 134; CCL20 PROTEIN, MOUSE; CXCL1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOMETRIUM CELL; EPITHELIUM CELL; ESTROGEN ACTIVITY; ESTRUS CYCLE; FEMALE; FEMALE GENITAL SYSTEM; HORMONAL REGULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; STROMA CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CYTOLOGY; DRUG EFFECTS; METABOLISM; SECRETION (PROCESS); STRUCTURE ACTIVITY RELATION; UTERUS; VAGINA;

ANIMALS; CHEMOKINE CCL20; CHEMOKINE CXCL1; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; FEMALE; MICE; MICE, INBRED BALB C; STRUCTURE-ACTIVITY RELATIONSHIP; UTERUS; VAGINA;

EID: 84872270364     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12021     Document Type: Article

References (28)

1. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L: Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005; 206:306-335.
2. King AE, Critchley HOD, Kelly RW: Innate immune defences in the human endometrium. Reprod Biol Endocrinol 2003; 1:116.
3. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM: Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001; 167:623-627.
4. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ: Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 2003; 74:448-455.
5. Ghosh M, Shen Z, Schaefer TM, Fahey JV, Gupta P, Wira CR: CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol 2009; 62:60-71.
6. Crane-Godreau MA, Wira CR: Effects of estradiol on lipopolysaccharide and Pam3Cys stimulation of CCL20/macrophage inflammatory protein 3 alpha and tumor necrosis factor alpha production by uterine epithelial cells in culture. Infect Immun 2005; 73:4231-4237.
7. Schaefer TM, Wright JA, Pioli PA, Wira CR: IL-1beta-mediated proinflammatory responses are inhibited by estradiol via down-regulation of IL-1 receptor type I in uterine epithelial cells. J Immunol 2005; 175:6509-6516.
8. Soboll G, Crane-Godreau MA, Lyimo MA, Wira CR: Effect of oestradiol on PAMP-mediated CCL20/MIP-3 alpha production by mouse uterine epithelial cells in culture. Immunology 2006; 118:185-194.
9. Coleman K, Wright J, Ghosh M, Wira C, Fahey J: Estradiol modulation of hepatocyte growth factor by stromal fibroblasts in the female reproductive tract. Fertil Steril 2009; 92:1107-1109.
10. Haddad SN, Wira CR: Keratinocyte growth factor stimulates macrophage inflammatory protein 3alpha and keratinocyte-derived chemokine secretion by mouse uterine epithelial cells. Am J Reprod Immunol 2010; 64:197-211.
11. Keller MJ, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, Cole AL, Cole AM, Profy AT, Wira CR, Hogarty K, Herold BC: PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS 2007; 21:467-476.
12. Wira CR, Fahey JV: A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008; 22:1909-1917.
13. Dutertre M, Smith CL: Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther 2000; 295:431-437.
14. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engström O, Ohman L, Greene GL, Gustafsson JA, Carlquist M: Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997; 389:753-758.
15. Kian Tee M, Rogatsky I, Tzagarakis-Foster C, Cvoro A, An J, Christy RJ, Yamamoto KR, Leitman DC: Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell 2004; 15:1262-1272.
16. Wakeling AE, Dukes M, Bowler J: A potent specific pure antiestrogen with clinical potential. Cancer Res 1991; 51:3867-3873.
17. de Cupis A, Noonan D, Pirani P, Ferrera A, Clerico L, Favoni RE: Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells. Br J Pharmacol 1995; 116:2391-2400.
18. Yang C, Xu G, Li J, Wu X, Liu B, Yan X, Wang M, Xie Y: Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo. Bioorg Med Chem Lett 2005; 15:1505-1507.
19. Ning M, Zhou C, Weng J, Zhang S, Chen D, Yang C, Wang H, Ren J, Zhou L, Jin C, Wang M-W: Biological activities of a novel selective oestrogen receptor modulator derived from raloxifene (Y134). Br J Pharmacol 2007; 150:19-28.
20. Compton DR, Sheng S, Carlson KE, Rebacz NA, Lee IY, Katzenellenbogen BS, Katzenellenbogen JA: Pyrazolo[1, 5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity. J Med Chem 2004; 47:5872-5893.
21. Wira CR, Rossoll RM: Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 1995; 136:4526-4534.
22. Grant KS, Wira CR: Effect of mouse uterine stromal cells on epithelial cell transepithelial resistance (TER) and TNFalpha and TGFbeta release in culture. Biol Reprod 2003; 69:1091-1098.
23. Wada-Hiraike O, Hiraike H, Okinaga H, Imamov O, Barros RPA, Morani A, Omoto Y, Warner M, Gustafsson J-A: Role of estrogen receptor beta in uterine stroma and epithelium: insights from estrogen receptor beta-/- mice. Proc Natl Acad Sci USA 2006; 103:18350-18355.
24. Hall JM, Couse JF, Korach KS: The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001; 276:36869-36872.
25. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson J-A: Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007; 87:905-931.
26. Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J: The structure of human macrophage inflammatory protein-3alpha/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem 2002; 277:37647-37654.
27. Entrican G, Wheelhouse NM: Immunity in the female sheep reproductive tract. Vet Res 2006; 37:295-309.
28. Hazrati E, Galen B, Lu W, Wang W, Ouyang Y, Keller MJ, Lehrer RI, Herold BC: Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol 2006; 177:8658-8666.